专利检索 ap:("Bayer Schering Pharma Aktiengesellschaft") AND inv:"PAULUS, Patrick" 第 1 页

1.

发明公开
INHIBITORS OF HYPOXIA INDUCIBLE FACTOR (HIF) USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS 审中-公开
标题翻译：缺氧诱导因子，用于治疗和过度增生性血管生成相关的疾病抑制剂（HIF）

公开(公告)号：EP2148877A2

公开(公告)日：2010-02-03

申请号：EP08758408.2

申请日：2008-05-08

申请人： Bayer Schering Pharma Aktiengesellschaft

发明人： BOYER, Stephen , HÄRTER, Michael , WICKENS, Philip , PATEL, Manoj , KUMARASINGHE, Ellalahewage, Sathyajith , BHARGAVA, Ajay, Kumar , THIERAUCH, Karl-Heinz , BECK, Hartmut , GRESCHAT, Susanne , ELLINGHAUS, Peter , PAULUS, Patrick , HESS-STUMPP, Holger

IPC分类号： C07D403/04 , C07D413/04 , C07D413/14 , C07D471/04 , C07D491/04 , A61K31/4245 , A61P35/00

CPC分类号： C07D413/04 , C07D403/04 , C07D413/14 , C07D471/04 , C07D491/04

摘要： This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients or therapeutic measures.